From target to lead: Designing and optimising AI discovered therapeutics for women's health
09 Sept 2026
Lead Generation & Optimization
- AI-discovered molecules show a 2X Phase I success rate against a historic averages — is that evidence of genuinely better molecule selection?
- What are typical and best-in-class hit rates for AI-discovered molecules
- As platforms like NVIDIA's and Lilly's TuneLab give smaller biotechs access to proprietary-scale models, does that meaningfully close the data gap?
- With so many inflated AI performance claims circulating, what evidence actually moves a skeptical partner or investor from doubt to belief?
Industry Expert
